$15 Million Series B Preferred Stock Offering of Life Sciences Company
Medical Diagnostics Company
Representation of a rapid assay medical diagnostics company in its $15 million offering of Series B Preferred Stock to accredited investors in a private placement.
Related Practices
RELATED PEOPLE
Partner
Practice Group Leader, Corporate & Finance
Associate
MORE EXPERIENCE
Representation of B piece and special servicer clients, handling in excess of $130billion in 2.0 CMBSsecuritizations.
Representation of an energy company in its $9.45 billion all-cash acquisition of another energy company, resulting in the creation of the largest utility holding company in the United States.
Handled the sale of over 2,000 REOs, with aggregate purchase prices in the billions of dollars, through both the negotiation and closing of individual sales and the structuring and sale by auction of multiple properties. The largest was approximately $216 million, which was the sale of a major hotel...